CSF measurements of Aβ1−42, t-tau, and p-tau in FTLD differ significantly from the abnormal levels seen in AD, and in a subset of both FTLD-tau and FTLD-TDP there are extremely low levels of t-tau of unclear etiology. Here, MAPT is linked to Alzheimer disease.